AAV Capsid Engineering
Development of novel AAV capsids for gene therapy
Revvity Gene Delivery, where SIRION Biotech’s expertise lives on, has been supporting pharmaceutical and biotech organizations for years enabling targeted gene therapy by providing our IP and know-how in AAV capsid engineering, creating new intellectual property (IP) tailored specifically to our partner’s needs.
AAV capsid directed evolution
AAV rational design – nanobody targeting
Please note that product labeling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.